Stockscreener 앱 받기
2.925
22.82%
-0.865
시간 외 거래:
2.97
0.045
+1.54%
전일 마감가:
$3.79
열려 있는:
$3.1
하루 거래량:
2.22M
Relative Volume:
2.76
시가총액:
$492.53M
수익:
$193.01M
순이익/손실:
$-12.15M
주가수익비율:
-32.50
EPS:
-0.09
순현금흐름:
$454.00K
1주 성능:
-24.22%
1개월 성능:
-21.79%
6개월 성능:
-58.51%
1년 성능:
-52.82%
1일 변동 폭
$2.865
$3.47
1주일 범위
$2.865
$3.89
52주 변동 폭
$2.865
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
명칭
Cytek Biosciences Inc
전화
(877) 922-9835
주소
47215 LAKEVIEW BOULEVARD, FREMONT
CTKB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
2.925 | 492.53M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-31 | 다운그레이드 | Goldman | Buy → Sell |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
Cytek Biosciences First Quarter 2025 Earnings: Misses Expectations - Yahoo
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2025 Earnings Call Transcript - Insider Monkey
Dimensional Fund Advisors LP Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates - MSN
Cytek Biosciences: Earnings Call Reveals Mixed Fortunes - TipRanks
Cytek Biosciences stock rating cut, price target drops to $4 By Investing.com - Investing.com Canada
TD Cowen Downgrades Cytek Biosciences to Hold From Buy, Adjusts Price Target to $4 From $7 - marketscreener.com
Cytek Biosciences (CTKB) Downgraded to Hold as Challenges Persist | CTKB Stock News - GuruFocus
Cytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold - TipRanks
Cytek Biosciences Reports First Quarter 2025 Financial Results - GlobeNewswire
Cytek Biosciences Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Cytek Biosciences misses Q1 2025 earnings forecasts - Investing.com
Cytek Biosciences, Inc. SEC 10-Q Report - TradingView
Cytek Biosciences (CTKB) Reports Q1 Revenue Below Expectations | CTKB Stock News - GuruFocus
What To Expect From Cytek Biosciences Inc (CTKB) Q1 2025 Earnings - Yahoo Finance
Raymond James Financial Inc. Invests $765,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued? (NASDAQ:CTKB) - Seeking Alpha
Wells Fargo & Company MN Acquires 15,516 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Barclays PLC Purchases 14,065 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek BioSciences Inc (NASDAQ: CTKB) Up 4.32%: This Is What Analysts Are Now Forecasting - Stocksregister
XTX Topco Ltd Trims Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Invesco Ltd. - Defense World
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025 - GlobeNewswire
Revolutionary Cell Analysis Technology Takes Center Stage: Cytek's FSP Debuts at CYTO & IMMUNOLOGY2025 - Stock Titan
Why Cytek Biosciences Should Beat Q1 Earnings Expectations - Seeking Alpha
Analysts Predict Cytek BioSciences Inc (NASDAQ:CTKB) To Reach 8 In 12 Months - Marketing Sentinel
Russell Investments Group Ltd. Has $180,000 Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Market Insights: Cytek BioSciences Inc (CTKB)’s Notable Gain of 1.33, Closing at 3.82 - DWinneX
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Cytek Biosciences to Announce Q1 2025 Financial Results and Host Webcast on May 8, 2025 - Nasdaq
Cytek Biosciences Q1 2025 Earnings: Key Financial Updates Coming May 8What to Watch - Stock Titan
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Is Cytek Biosciences (NASDAQ:CTKB) Using Too Much Debt? - simplywall.st
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Decreases Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by American Century Companies Inc. - Defense World
KLP Kapitalforvaltning AS Takes $131,000 Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.51 amid market challenges - Investing.com
Trading (CTKB) With Integrated Risk Controls - news.stocktradersdaily.com
Prudential Financial Inc. Has $1.13 Million Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Raymond James Financial Inc. Buys New Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Thrivent Financial for Lutherans Sells 3,001 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cell Analyzer | Cytek Biosciences Inc. | Products - Photonics Spectra
106,597 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Purchased by Teacher Retirement System of Texas - Defense World
Proficio Capital Partners LLC Invests $71,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.99 amid market shifts - Investing.com India
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by PNC Financial Services Group Inc. - Defense World
Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek Muse Micro System - SelectScience
Charles Schwab Investment Management Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.2% – What’s Next? - Defense World
Cytek Biosciences Inc (CTKB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.79%
자본화:
|
볼륨(24시간):